| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 05/31/2011 | US7951923 Fluorescent proteins and chromoproteins from non-Aequorea hydrozoa species and methods for using same |
| 05/31/2011 | US7951785 NFIA in glial fate determination, glioma therapy and astrocytoma treatment |
| 05/31/2011 | US7951784 modified small interfering RNAs (siRNAs) that are stable in vivo and retain the ability to form an A-form helix when in association with a target RNA; gene expression inhibition; for treating amyotrophic lateral sclerosis associated with the activity of a protein specified by a target mRNA |
| 05/31/2011 | US7951775 Methods and pharmaceutical compositions for GnRH-I and GnRH-II modulation of T-cell activity, adhesion, migration and extravasation |
| 05/31/2011 | US7951753 Plant chimeric binding polypeptides for universal molecular recognition |
| 05/31/2011 | US7951604 Mixtures for assaying nucleic acid, novel method of assaying nucleic acid with the use of the same and nucleic acid probe to be used therefor |
| 05/31/2011 | US7951596 Nucleic acid nanotube liquid crystals and use for NMR structure determination of membrane proteins |
| 05/31/2011 | US7951595 Methods for screening modulators of SLC17-type anion transport activity |
| 05/31/2011 | US7951586 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using such DNA sequences |
| 05/31/2011 | US7951571 Variant Humicola grisea CBH1.1 |
| 05/31/2011 | US7951570 CBH1 homologs and variant CBH1 cellulases |
| 05/31/2011 | US7951569 Thermostable duplex-specific nuclease |
| 05/31/2011 | US7951568 Bi-directional selection markers with improved activity |
| 05/31/2011 | US7951564 Primers for amplifying mononucleotide satellite markers |
| 05/31/2011 | US7951562 Method for glycosylating hydroxylysine residues in polypeptides or peptides |
| 05/31/2011 | US7951560 Delta 4,5 glycuronidase compositions and methods related thereto |
| 05/31/2011 | US7951557 Human lysosomal proteins from plant cell culture |
| 05/31/2011 | US7951540 Sequences diagnostic for shrimp pathogens |
| 05/31/2011 | US7951538 Method to determine the risk for side effects of an SSRI treatment in a person |
| 05/31/2011 | US7951537 Development of low allergen soybean seeds using molecular markers for the P34 allele |
| 05/31/2011 | US7951536 Method for determining base sequence of DNA |
| 05/31/2011 | US7951535 detecting targets in humans or animal cells, comprising administering oligonucleotide-based surface-enhanced Raman spectroscopy molecular probes, including nanoparticle having a metal component and a sequence complementary to target sequences; activation with radiation and comparing signal generated |
| 05/31/2011 | US7951533 Structure determining method of functional substance having affinity to biomolecule or chemical, and method for producing functional substance |
| 05/31/2011 | US7951386 Recombinant cytochrome oxidase and/or morula membrane protein for use in developing therapeutics which prevent infection associated with mite parasitfes |
| 05/31/2011 | US7951375 Methods of inducing an immune response |
| 05/31/2011 | US7951366 Recombinant human arginase functioning as arginine depleting agent in treatment of cell proliferative disorders |
| 05/31/2011 | US7951360 Mutant interleukin-2 (IL-2) polypeptides |
| 05/31/2011 | US7951357 Implantable power sources and sensors |
| 05/31/2011 | CA2588581C Detection of nucleic acids from multiple types of human papillomaviruses |
| 05/31/2011 | CA2460759C Diagnostic probe detection system |
| 05/31/2011 | CA2339324C Protein delivery system using human papillomavirus virus-like particles |
| 05/31/2011 | CA2237356C Methods for diagnosis and treatment of bloom's syndrome |
| 05/26/2011 | WO2011063411A1 Elite event ee-gm3 and methods and kits for identifying such event in biological samples |
| 05/26/2011 | WO2011063348A1 Monomeric antibody fc |
| 05/26/2011 | WO2011062904A1 Transgenic maize event mon 87427 and the relative development scale |
| 05/26/2011 | WO2011062862A1 Improved bacterial membrane protein secrection |
| 05/26/2011 | WO2011061115A1 Solid phase-bound nucleosides |
| 05/26/2011 | WO2011061114A1 Method for producing trinucleotides |
| 05/26/2011 | WO2010105097A8 Sparc angiogenic domain and methods of use |
| 05/26/2011 | WO2007001928A3 Targets for inhibiting hcv replication |
| 05/26/2011 | US20110126327 Herbicide resistant barley |
| 05/26/2011 | US20110126326 Strong activation domain |
| 05/26/2011 | US20110126325 Recombinant cells and methods for hydroxylating fatty acids |
| 05/26/2011 | US20110126321 Recombinant dna for gene suppression |
| 05/26/2011 | US20110126319 Plants Having Increased Oil, Oleic Acid Content and Digestibility and Methods of Producing Same |
| 05/26/2011 | US20110126318 Sucrose transporter genes for increasing plant seed lipids |
| 05/26/2011 | US20110126314 Modulation of coffee flavour precursor levels in green coffee grains |
| 05/26/2011 | US20110126312 Method for improving salinity tolerance |
| 05/26/2011 | US20110126310 Transgenic maize event mon 87427 and the relative development scale |
| 05/26/2011 | US20110126309 Methods and compositions for identifying downy mildew resistant cucumber plants |
| 05/26/2011 | US20110126307 Chloroplast transit peptides for efficient targeting of dmo and uses thereof |
| 05/26/2011 | US20110126305 Mutant blue fluorescent protein and method of using the same for fluorescence resonance energy transfer and blue fluorescent fish |
| 05/26/2011 | US20110126303 Modified Blood Clotting Factors And Methods Of Use |
| 05/26/2011 | US20110126302 Diagnostic and therapeutic methods for efmr (epilepsy and mental retardation limited to females) |
| 05/26/2011 | US20110126301 Dendritic Cell Marker and Uses Thereof |
| 05/26/2011 | US20110124853 Conjugates and Compositions for Cellular Delivery |
| 05/26/2011 | US20110124852 Molecular markers for identification of fat and lean phenotypes in chickens |
| 05/26/2011 | US20110124851 Method of Isolation of Nucleic Acids |
| 05/26/2011 | US20110124841 Polypeptides Modified by Protein Trans-Splicing Technology |
| 05/26/2011 | US20110124715 Antiviral Oligonucleotides Having a Conserved G4 Core Sequence |
| 05/26/2011 | US20110124714 pDJA1, a cardiac specific gene, corresponding proteins, and uses thereof |
| 05/26/2011 | US20110124713 Sam-ii riboswitch and uses thereof |
| 05/26/2011 | US20110124712 Anti-cancer composition comprising microrna molecules |
| 05/26/2011 | US20110124711 COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF Nav1.8 GENE |
| 05/26/2011 | US20110124710 Composition and methods of rnai therapeutics for treatment of cancer and other neovascularization diseases |
| 05/26/2011 | US20110124709 Rna antagonists targeting gli2 |
| 05/26/2011 | US20110124582 Novel polypeptide having anti-tumor activity |
| 05/26/2011 | US20110124581 Nucleic and amino acid sequences for the control of pathogen agents |
| 05/26/2011 | US20110124576 Transferrin Variants and Conjugates |
| 05/26/2011 | US20110124571 Opiorphin peptide derivatives as potent inhibitors of enkephalin-degrading ectopeptidases |
| 05/26/2011 | US20110124565 Modified Coagulation Factor VIII With Enhanced Stability and Its Derivatives |
| 05/26/2011 | US20110124554 Fibrosuppressant Biotherapeutics |
| 05/26/2011 | US20110124529 Apparatus and Method for Polymer Synthesis Using Arrays |
| 05/26/2011 | US20110124510 Methods of labeling polynucleotide with dibenzorhodamine dyes |
| 05/26/2011 | US20110124109 Dna molecules and methods |
| 05/26/2011 | US20110124102 Rage Fusion Proteins And Methods Of Use |
| 05/26/2011 | US20110124101 Methods and devices for producing biomolecules |
| 05/26/2011 | US20110124099 Ikkalpha and ikkbeta specific inhibitors |
| 05/26/2011 | US20110124090 Gene involved in the biosyntheses of lycopene, recombinant vector comprising the gene, and transformed microorganism with the recombinant vector |
| 05/26/2011 | US20110124085 Unsymmetrical cyanine dimer compounds and their application |
| 05/26/2011 | US20110124084 Proteases |
| 05/26/2011 | US20110124082 Mutant glycoprotein resistant to modification with asparagine-linked sugar chain |
| 05/26/2011 | US20110124077 Mobile magnetic traps and platforms for micro/nano particle manipulation |
| 05/26/2011 | US20110124074 Heterologous Expression of Fungal Cellobiohydrolases in Yeast |
| 05/26/2011 | US20110124066 Production of itaconic acid |
| 05/26/2011 | US20110124065 Cellular production of glucaric acid |
| 05/26/2011 | US20110124058 Recombinant thermoascus aurantiacus beta-glucosidase variants for production of fermentable sugars from cellulosic biomass |
| 05/26/2011 | US20110124047 Vmp-like sequences of pathogenic borrelia species and strains |
| 05/26/2011 | US20110124046 Extracellular Secretion of Recombinant Proteins |
| 05/26/2011 | US20110123992 Probe, probe set, probe carrier, and testing method |
| 05/26/2011 | US20110123982 Nucleic acid based fluorescent sensor for copper detection |
| 05/26/2011 | US20110123602 Molecular lymphatic mapping of sentinel lymph nodes |
| 05/26/2011 | US20110123565 Structural Proteins of Fish Pancreatic Disease Virus and Uses Thereof |
| 05/26/2011 | US20110123561 Methods and compositions for induction or promotion of immune tolerance |
| 05/26/2011 | US20110123552 Agonistic binding molecules to the human OX40 receptor |
| 05/26/2011 | US20110123538 Composition comprising expression or activity inhibitors of ninjurin 1 for the prevention and treatment of inflammatory disease |
| 05/26/2011 | US20110123536 Novel human anti-r7v antibodies and uses thereof |
| 05/26/2011 | US20110123534 Novel compounds for modulating neovascularisation and methods of treatment using these compounds |
| 05/26/2011 | US20110123532 Method for Making Heteromultimeric Molecules |
| 05/26/2011 | US20110123529 Single domain antibodies directed against epidermal growth factor receptor and uses therefor |